A Day Up For Elevation Oncology Inc.
Wed, Mar 15, 2023 at 07:06 PM
Elevation Oncology Inc. (ELEV:NASDAQ) rocketted at $2.32, a gain of 62.2%. On Wed, Mar 15, 2023, ELEV:NASDAQ touched a New 2-Week High of $2.32. The stock got featured on our News Catalysts scanner on Tue, Mar 14, 2023 at 05:35 PM in the 'BIOTECH' category. From Wed, Mar 01, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 98.58%
- Elevation Oncology Inc. (ELEV:NASDAQ), 62.24%
- Loyalty Ventures Inc. (LYLT:NASDAQ), 59.35%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 40.57%
- Mmtec, Inc. (MTC:NASDAQ), 35.75%
- Creatd Inc. (CRTD:NASDAQ), 32.74%
- Moolec Science SA (MLEC:NASDAQ), 25.16%
- Summit Healthcare Acquisition Corp. (SMIH:NASDAQ), 22.3%
- Etao International Co. Ltd. (ETAO:NASDAQ), 21.52%
- GreenLight Biosciences Holdings PBC (GRNA:NASDAQ), 21.46%